Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Nanotech being used in the fight against cancer

Abstract:
Cancer treatments complemented with nanomaterials may be more effective than traditional treatments alone such as chemotherapy and radiation, say researchers from Nazarbayev University.

Nanotech being used in the fight against cancer

Nur-Sultan City, Kazakhstan | Posted on November 27th, 2019

Diagnoses and death rates due to cancer are rising year after year, with current treatments including surgery, radiation, and chemotherapy. However, the multitude of limitations and side effects these treatments have mean alternative approaches are needed.

Researcher Zhannat Ashikbayeva, Professor Daniele Tosi, and Professor Vassilis Inglezakis, focused on the application of nanomaterials in thermal ablation therapy. Thermal ablation is a technique used in cancer therapy to eliminate cancerous cells or tissue by applying external electromagnetic waves to locally increase the temperature.

However, the choice of a suitable heat delivery route to the cancerous tissue is a problem as existing methods show difficulty in differentiating between tumours and surrounding healthy tissue, leading to the damage of non-cancerous cells. The use of nanomaterials is an attractive solution as the nanomaterials can trigger heat increase in specific tumour regions. This allows the therapy to target and destroy the cancer cells specifically without adversely affecting healthy surrounding cells. This technique is flexible, low cost, and minimally invasive.

Prof. Inglezakis, Associate Professor of Chemical & Materials Engineering, said: “The goal is not to replace existing therapies but complement in a way that is beneficial to the patient. This should reduce side-effects and help to remove harmful by-products that are produced when patients undergo traditional cancer treatments.”

At present, scientists have successfully tested nanomaterials to heat animal tissues in vitro but the translation to commercial clinical use on human patients has not yet occurred. The researchers of this project aim to stimulate further research into the use of nanomaterials in cancer treatments.

####

For more information, please click here

Contacts:
Kyle Grizzell
Phone: 01582 790709

Copyright © Nazarbayev University

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Self-driving microrobots December 10th, 2019

CEA-Leti Thin-Film Batteries Target Extended Applications and Improved Performance in Medical Implants: IEDM 2019 Paper Reports Millimeter-Scale TFBs Exhibit the Best Performance In Both Energy and Power Densities December 10th, 2019

Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million December 7th, 2019

'Buildings' in human bone may hold key to stronger 3D-printed lightweight structures December 6th, 2019

Cancer

Nanoparticle orientation offers a way to enhance drug delivery: Coating particles with 'right-handed' molecules could help them penetrate cancer cells more easily November 5th, 2019

New drug-delivery technology promises efficient, targeted cancer treatment October 22nd, 2019

Novel nanogels hold promise for improved drug delivery to cancer patients: 'Precision Medicine' approach underpins UT Austin engineers' development of multifunctional nanogel September 27th, 2019

SMART announces a revolutionary tech to study cell nanomechanics: New research discovery enables scientists to study membrane mechanics of cell's nucleus, revolutionising the understanding of metastatic cancers as well as opening the doors for identification of stem cells for the September 20th, 2019

Possible Futures

Self-driving microrobots December 10th, 2019

CEA-Leti Thin-Film Batteries Target Extended Applications and Improved Performance in Medical Implants: IEDM 2019 Paper Reports Millimeter-Scale TFBs Exhibit the Best Performance In Both Energy and Power Densities December 10th, 2019

'Buildings' in human bone may hold key to stronger 3D-printed lightweight structures December 6th, 2019

Artificial cells act more like the real thing December 6th, 2019

Nanomedicine

Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million December 7th, 2019

Artificial cells act more like the real thing December 6th, 2019

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock December 5th, 2019

Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock December 3rd, 2019

Discoveries

Artificial cells act more like the real thing December 6th, 2019

Scientists see defects in potential new semiconductor: Discovery could help in effort to make high-powered electronics more efficient December 5th, 2019

Electro-optical device provides solution to faster computing memories and processors: First-of-a-kind electro-optical device provides solution to faster and more energy efficient computing memories and processors December 2nd, 2019

Growing nano-tailored surfaces using micellar brushes November 29th, 2019

Announcements

Self-driving microrobots December 10th, 2019

CEA-Leti Thin-Film Batteries Target Extended Applications and Improved Performance in Medical Implants: IEDM 2019 Paper Reports Millimeter-Scale TFBs Exhibit the Best Performance In Both Energy and Power Densities December 10th, 2019

Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million December 7th, 2019

'Buildings' in human bone may hold key to stronger 3D-printed lightweight structures December 6th, 2019

Nanobiotechnology

Arrowhead Pharmaceuticals Closes Underwritten Public Offering with Gross Proceeds of $266.8 Million December 7th, 2019

Artificial cells act more like the real thing December 6th, 2019

Arrowhead Pharmaceuticals Announces Pricing of Underwritten Public Offering of Common Stock December 5th, 2019

Arrowhead Pharmaceuticals Announces Proposed Underwritten Offering of Common Stock December 3rd, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project